BRIEF published on 02/16/2026 at 17:55, 3 months ago Aramis Group Discloses Share Buybacks in February 2026 Euronext Paris Share Buyback Aramis Group February 2026 Online Used Car Sales
BRIEF published on 02/16/2026 at 17:55, 3 months ago Le groupe Aramis annonce des rachats d'actions en février 2026 Rachat D'actions Euronext Paris Groupe Aramis Février 2026 Vente De Voitures D'occasion En Ligne
BRIEF published on 02/16/2026 at 17:51, 3 months ago HBM Healthcare Reports February 2026 Financial Performance Financial Figures Share Price NAV HBM Healthcare February 2026
BRIEF published on 02/16/2026 at 17:51, 3 months ago HBM Healthcare publie ses résultats financiers de février 2026 NAV Données Financières Prix De L'action HBM Healthcare Février 2026
BRIEF published on 02/16/2026 at 17:50, 3 months ago FIGEAC AÉRO Renforce son Partenariat sur le Moteur M88 du Rafale FIGEAC AÉRO Moteur M88 Safran Engines Programme Rafale Production France
BRIEF published on 02/16/2026 at 17:50, 3 months ago FIGEAC AÉRO Secures New Agreement for Rafale Engine Component Business Growth FIGEAC AÉRO Aerospace Manufacturing Safran Partnership Rafale Engine
BRIEF published on 02/16/2026 at 17:50, 3 months ago FIGEAC AÉRO Strengthens its Partnership on the Rafale M88 Engine FIGEAC AÉRO M88 Engine Safran Engines Rafale Program Produced In France
BRIEF published on 02/16/2026 at 17:50, 3 months ago FIGEAC AÉRO conclut un nouvel accord pour un composant moteur du Rafale Croissance De L'entreprise FIGEAC AÉRO Fabrication Aérospatiale Partenariat Safran Moteur Rafale
BRIEF published on 02/16/2026 at 17:50, 3 months ago Newron Pharmaceuticals Secures EUR 38 Million for Phase III Evenamide Program Financing Newron Pharmaceuticals Evenamide Phase III Trials Treatment-resistant Schizophrenia
BRIEF published on 02/16/2026 at 17:50, 3 months ago Newron Pharmaceuticals obtient 38 millions d'euros pour son programme de phase III sur l'événamide. Financement Newron Pharmaceuticals Evenamide Essais De Phase III Schizophrénie Résistante Au Traitement
Published on 05/16/2026 at 01:15, 1 day ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 1 hour ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 2 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 2 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 9 hours 18 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 5 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 7 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 10 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 10 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 15 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 16 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 7 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
